Acute coronary syndromes in patients with end stage renal disease resulting from diabetes after renal transplantation compared with patients on the renal transplant waiting list

2001 ◽  
Vol 37 (4) ◽  
pp. A19
Author(s):  
Iman O. Hypolite ◽  
Jay Bucci ◽  
Christina M. Yuan ◽  
Allan Taylor ◽  
Paul Hshieh ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Renal Transplant ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Acute Coronary Syndromes ◽  
Waiting List ◽  
Coronary Syndromes ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Acute Coronary Syndromes after Renal Transplantation in Patients with End-Stage Renal Disease Resulting from Diabetes

2002 ◽  
Vol 2 (3) ◽  
pp. 274-281 ◽  
Author(s):  
Iman O. Hypolite ◽  
Jay Bucci ◽  
Paul Hshieh ◽  
David Cruess ◽  
Lawrence Y. C. Agodoa ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Acute Coronary Syndromes ◽  
Coronary Syndromes ◽  
Stage Renal Disease ◽  
End Stage

Potential Nontraditional Applications of Statins

2003 ◽  
Vol 37 (7-8) ◽  
pp. 1063-1071 ◽  
Author(s):  
James M McKenney
Keyword(s):  
Peripheral Arterial Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Acute Coronary Syndromes ◽  
Arterial Disease ◽  
Data Sources ◽  
Coronary Syndromes ◽  
Peripheral Arterial ◽  
Stage Renal Disease ◽  
End Stage

OBJECTIVE: To review the current evidence for use of hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) in nontraditional lipid-related applications, including acute coronary syndromes, peripheral arterial disease, stroke, and renal disease, and to describe ongoing trials evaluating the role of statins in these conditions. DATA SOURCES: Clinical literature was identified by a MEDLINE search (1990–November 2002) using ≥1 of the following search terms: acute coronary syndrome(s), angina pectoris, atherosclerosis, atorvastatin, clinical trials, diabetes mellitus, end-stage renal disease, fluvastatin, lovastatin, myocardial infarction, peripheral arterial disease, pravastatin, simvastatin, statins, and stroke. Treatment guidelines issued by professional and governmental organizations, such as the American Diabetes Association, American Heart Association, National Cholesterol Education Program, National Kidney Foundation, and National Stroke Foundation, were reviewed. STUDY SELECTION AND DATA EXTRACTION: Articles identified from the data sources were included if they pertained to the conditions described in the objectives and provided unique information concerning use of statins. DATA SYNTHESIS: Substantial evidence exists for the use of statins in acute coronary syndromes. Meta-analyses of data from major clinical trials indicate that statins prevent first and recurrent stroke, and large-scale trials are underway to evaluate the efficacy of statins in this setting. Accumulating evidence suggests that statins may be beneficial in reducing the morbidity and mortality associated with peripheral arterial disease and end-stage renal disease, and results from ongoing trials may confirm these benefits. Statins may also have a future role in amelioration of other conditions associated with atherosclerosis, such as diabetes mellitus. CONCLUSIONS: A large body of evidence supports the evaluation of statins in clinical settings beyond primary and secondary prevention of morbidity and mortality associated with coronary atherosclerosis.

scholarly journals Anesthesia management of renal transplantation: A retrospective analysis

2021 ◽  
Vol 8 (2) ◽  
pp. 172-178
Author(s):  
Pradeep Tiwari ◽  
Aarti Kulkarni ◽  
Shraddha Mathkar
Keyword(s):  
Renal Transplantation ◽  
Renal Transplant ◽  
Renal Disease ◽  
Retrospective Analysis ◽  
End Stage Renal Disease ◽  
Anesthesia Management ◽  
Co Morbidity ◽  
Stage Renal Disease ◽  
End Stage ◽  
Preoperative Patient

Transplantation provides a near normal life and excellent rehabilitation compared to dialysis and is preferred method of treatment for end stage renal disease patients. After ethics committee approval, a retrospective analysis of recipients of renal transplantation was done at our hospital from January 2010 to December 2014. Preoperative patient status, fluid management, hemodynamic parameters, anesthesia management, and perioperative complications were recorded and analyzed.Total 100 patients were recorded, 92% living and 8% were cadaveric related transplant. 92% were done electively. Most common co-morbidity recorded was hypertension in 49% patients. Predominant cause of end stage renal disease was chronic glomerulonephritis (41%). General anesthesia was technique of choice in all patients, 27 also received epidural. Invasive blood pressure monitoring was done in 3 patients with cardiac co-morbidities. 15% patients required blood transfusion. CVP maintained > 12 mmHg and maximum at de-clamping. Mean arterial pressure maintained above 95 mmHg. Ionotropic support required in 2 patients. 76% patients were transfused with only crystalloid (NS and/or RL) while 24 patients received a combination of both crystalloid and colloid. 97% patients were extubated postoperatively while 3% required ventilator support. Recovery time with desflurane was significantly less as compared to other inhalational agents. One patient died postoperatively. Recent advances in surgical techniques, anesthesia management and immunosuppressive drugs have made renal transplantation safe and predictable. Preoperative patient optimization, intraoperative physiological stability and postoperative care of renal transplant patients have contributed to the success of renal transplant program in our hospital.

scholarly journals Electroconvulsive Therapy in a Renal Transplantation Patient: A Rare Combination of Disease and Treatment

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Giovanni Malaty ◽  
Kerilyn Godbe ◽  
Mehdi Elmouchtari ◽  
Gurjot Malhi ◽  
Justin White ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Renal Transplant ◽  
Renal Disease ◽  
Electroconvulsive Therapy ◽  
End Stage Renal Disease ◽  
Psychotic Symptoms ◽  
Safety And Efficacy ◽  
History Of ◽  
Stage Renal Disease ◽  
End Stage

The safety and efficacy of electroconvulsive therapy (ECT) for the treatment of psychiatric disorders have been demonstrated in a wide variety of patients, including postoperative patients and those who are pregnant. While several reports highlight the safety of this treatment in heart and liver transplantation patients, there is a relative lack of literature detailing the safety profile of ECT in an individual with recent kidney transplantation. Here, we explore the case of a patient with a recent renal transplant secondary to diabetes-related end-stage renal disease (ESRD) who underwent a successful course of ECT treatment. A 57-year-old Caucasian male with a past psychiatric history of schizoaffective disorder, bipolar type, and a past medical history of end-stage renal disease with recent right renal transplantation was admitted to the inpatient psychiatry unit. The admission was via a temporary detention order (TDO) for suicidality and auditory hallucinations promoting self-harm. The patient’s depressive and delusional history was well-documented and had been refractory to several courses of psychotherapeutic and pharmacologic management. Electroconvulsive therapy was subsequently initiated and was well-tolerated. Treatments progressively alleviated his depressive and psychotic symptoms and did not adversely affect the function of his transplanted kidney, which was closely monitored throughout the treatment process. This case demonstrated the safety and efficacy of ECT treatment in an individual with recent renal transplant and may prompt further trials into establishing safety and efficacy in larger study populations.

scholarly journals Scintigraphic diagnosis of infectious complications in renal failure patients undergoing hemodialysis, continuous ambulatory peritoneal dialysis or renal transplant

2005 ◽  
Vol 48 (spe2) ◽  
pp. 97-108 ◽  
Author(s):  
Ana María García Vicente ◽  
Sebastián Ruiz Solís ◽  
Angel Soriano Castrejón ◽  
Víctor Manuel Poblete García ◽  
Maria del Prado Talavera Rubio ◽  
...  
Keyword(s):  
Renal Failure ◽  
Peritoneal Dialysis ◽  
Renal Transplantation ◽  
Renal Transplant ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Infectious Complications ◽  
Nuclear Techniques ◽  
Stage Renal Disease ◽  
End Stage

Patients with end-stage renal disease have two therapeutic options, dialysis and renal transplantation. Infectious complications occurring in such patients will not only condition the effectiveness of such treatments, but are among the main causes of morbidity and mortality in such cases. Knowledge of the advantages and limitations of nuclear techniques is essential for management of these conditions.

scholarly journals Five Years of Renal Transplantations in Montenegro: Results and Challenges

2017 ◽  
Vol 15 (1) ◽  
pp. 41-42
Author(s):  
Marina Ratkovic ◽  
Nikolina Basic-Jukic ◽  
Zeljko Kastelan ◽  
Danilo Radunovic ◽  
Vladimir Prelevic ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Renal Allograft ◽  
Deceased Donor ◽  
Living Donors ◽  
Waiting List ◽  
Stage Renal Disease ◽  
End Stage ◽  
Renal Transplantations

Abstract First renal transplantation in Montenegro was performed on September 25th, 2012. Since then, 32 transplantations have been performed. Only one was from deceased donor, the remaining were from living donors. 40.4% of all patients with end-stage renal disease currently live with the functioning renal allograft (190 patients on dialysis, 129 transplanted patients). There are 32 patients on the waiting list. Further efforts will be focused on development of the deceased donor program and introduction of the AB0 incompatible renal transplantations.

Sign in / Sign up

Export Citation Format

Share Document